Stock Track | Baxter Soars 5.03% in Pre-Market on Strong Q1 Earnings Beat and Upbeat Outlook

Stock Track
Apr 30

Baxter International Inc. (BAX) saw its shares surge 5.03% during pre-market trading on Thursday, following the release of its first-quarter 2026 financial results.

The medical products company reported adjusted earnings per share of $0.37, surpassing the Ibes consensus estimate of $0.31. Revenue for the quarter came in at $2,701 million, also beating expectations of $2,616 million. While the company reported a net loss of $15 million for the quarter, investors focused on the positive adjusted metrics.

Furthermore, Baxter provided its full-year outlook, forecasting adjusted EPS in the range of $1.85 to $2.05, which compares favorably to the Ibes estimate of $1.91. The combination of stronger-than-expected quarterly performance and a guidance that meets or exceeds analyst projections appears to have driven the positive investor sentiment in the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10